Globally, 3 out of 5 persons lose their lives to chronic inflammatory conditions, such as diabetes, cardiovascular disorders, cancer, chronic respiratory diseases, skin diseases, renal diseases and obesity. Inflammatory diseases are the most prevailing cause of death worldwide and the numbers keep rising.

The network focuses on reducing the burden of infectious and inflammatory diseases caused by pathogens, damaged cells, toxic compounds or radiation in order to develop new diagnostic and treatment technologies.

As a society, we need more knowledge about the correlation between e.g. inflammation and development of cancer, about biomarkers and about molecular mechanisms of autoimmunity in e.g. rheumatological conditions - not to mention chronic mucosal inflammation. In the inflammation network we collaborate interdisciplinearily in order to find answers.

We comprise a wide range of researchers with interest in diagnostic methods, epidemiological data, inflammatory markers and intracellular pathways, understanding of cell population and tissue structures, among others.



Subject-specific programmes for PhD students

The subject-specific PhD programme in inflammation at Aarhus University, Health, offers an in-depth, multidisciplinary study of inflammation's role in diseases and prevention, addressing its significant role in both non-communicable diseases (NCD) and infections.

For more information about the subject-specific programmes: Subject-specific programmes, Graduate School of Health (au.dk).


Paper of the month

Paper of the month, May 2026 is presented by Professor Trine Mogensen

Thymic health consequences in adults
Simon Bernatz, Vasco Prudente, Suraj Pai, Asbjørn K. Attermann, Yumeng Cao, Jiachen Chen, Asya Lyass, Borek Foldyna, Leonard Nürnberg, Keno Bressem, Christopher Abbosh, Charles Swanton, Mariam Jamal-Hanjani, Michael T. Lu, Joanne M. Murabito, Kathryn L. Lunetta, Nicolai J. Birkbak & Hugo J. W. L. Aerts
Nature 652, 986–994 (2026).
doi.org/10.1038/s41586-026-10242-y

In this seminal article published in Nature in April this year a large collaborative European-American team, including professor Nicolai Birkbak from Department of  Clinical Medicine at Aarhus University, investigated the thymus size by CT scans and correlated this to different health parameters in more than 27,000 individuals. They found that the thymus size inversely correlates with a number of diseases, implying that individuals with a small involuted thymus have a higher risk of cardiovascular disease and cancer and an overall increased mortality.